MedPath

clomiphene and letrozole in idiopathic oligospermic

Phase 2
Conditions
N40-N51
Male infertility.
Diseases of male genital organs
Registration Number
IRCT2016041721344N2
Lead Sponsor
Vice Chancellor for Research and Technology, Semnan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Male
Target Recruitment
80
Inclusion Criteria

Infertile men with sperm concentration, less than15 million per ml progressive motility, less than 32% total (progressive + non-progressive) motility,less than 40% , or morphologically normal forms,less than 4.0% ? exclusion criteria:Infertile male with Varicocele, Abnormal FSH and LH and TSH and Testestrone and Prolactin, Abnormal liver or kidney function tests.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Sperm concentration. Timepoint: one week after last medication. Method of measurement: Semen analysis.
Secondary Outcome Measures
NameTimeMethod
Sperm motility. Timepoint: one week after last medication. Method of measurement: Semen analysis.;Sperm morphology. Timepoint: one week after last medication. Method of measurement: Semen analysis.;Semen volume. Timepoint: one week after last medication. Method of measurement: Semen analysis.
© Copyright 2025. All Rights Reserved by MedPath